Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Pain Palliat Care Pharmacother. 2012 Jun;26(2):134-5. doi: 10.3109/15360288.2012.680011.

Are opioid risk evaluation and mitigation strategies (REMS) interrupting your sleep?

Author information

  • Department of Pharmacy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA. david.craig@moffitt.org

Abstract

The article entitled "Risk Evaluation and Mitigation Strategies (REMS) for Extended-Release and Long-Acting Opioid Analgesics: Considerations for Pain and Palliative Care Practice" that appears in this issue of the journal addresses the important new Food and Drug Administration (FDA) REMS program. This commentary expands on themes introduced by Dr. Gudin, projects future directions for REMS, and discusses possible benefits, limitations, and risks associated with the extended-release long-acting opioid REMS.

Comment on

PMID:
22764851
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Informa Healthcare
    Loading ...
    Write to the Help Desk